These findings are consistent with literature indicating that aberrant cilia function can contribute to tumorigenesis and metastasis.[41] Thus, targeting ACTR3 and its associated pathways may provide novel therapeutic avenues for CESC treatment. This evidence concerns the gene ACTR3 and cervical squamous cell carcinoma.